These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35182281)
1. Perceptions and Practicalities Influencing Pre-exposure Prophylaxis Adherence Among Men Who Have Sex with Men in England. Arnold-Forster D; Horne R; Nutland W; Wayal S; Rayment M; Rae C; Desai M; Clarke A; Sullivan A; McCormack S; Gafos M AIDS Behav; 2022 Aug; 26(8):2768-2782. PubMed ID: 35182281 [TBL] [Abstract][Full Text] [Related]
2. The Context of Sexual Risk Behaviour Among Men Who Have Sex with Men Seeking PrEP, and the Impact of PrEP on Sexual Behaviour. Gafos M; Horne R; Nutland W; Bell G; Rae C; Wayal S; Rayment M; Clarke A; Schembri G; Gilson R; McOwan A; Sullivan A; Fox J; Apea V; Dewsnap C; Dolling D; White E; Brodnicki E; Wood G; Dunn D; McCormack S AIDS Behav; 2019 Jul; 23(7):1708-1720. PubMed ID: 30306439 [TBL] [Abstract][Full Text] [Related]
3. "Sex without fear": exploring the psychosocial impact of oral HIV pre-exposure prophylaxis on gay men in England. Hayes R; Nutland W; Rayment M; Wayal S; Apea V; Clarke A; McOwan A; Sullivan A; Desai M; Jajja A; Rice B; Horne R; McCormack S; Gafos M AIDS Res Ther; 2023 Nov; 20(1):81. PubMed ID: 37964322 [TBL] [Abstract][Full Text] [Related]
4. Pre-exposure prophylaxis (PrEP) uptake and adherence experiences of gay and bisexual men who engage in chemsex: A qualitative study. Maxwell S; Shahmanesh M; Gafos M Int J Drug Policy; 2022 May; 103():103630. PubMed ID: 35231668 [TBL] [Abstract][Full Text] [Related]
5. Assessing determinants of pre-exposure prophylaxis (PrEP) adherence among a sample of rural Midwestern men who have sex with men (MSM). Owens C; Hubach RD; Lester JN; Williams D; Voorheis E; Reece M; Dodge B AIDS Care; 2020 Dec; 32(12):1581-1588. PubMed ID: 32338061 [TBL] [Abstract][Full Text] [Related]
6. Experiences of men who have sex with men when initiating, implementing and persisting with HIV pre-exposure prophylaxis. Gillespie D; Wood F; Williams A; Ma R; de Bruin M; Hughes DA; Jones AT; Couzens Z; Hood K Health Expect; 2022 Aug; 25(4):1332-1341. PubMed ID: 35426223 [TBL] [Abstract][Full Text] [Related]
7. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis. Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366 [TBL] [Abstract][Full Text] [Related]
8. Perceived influence of alcohol consumption, substance use, and mental health on PrEP adherence and condom use among PrEP-prescribed gay, bisexual, and other men-who-have-sex-with-men: a qualitative investigation. Shuper PA; Varatharajan T; Kinitz DJ; Gesink D; Joharchi N; Bogoch II; Loutfy M; Rehm J BMC Public Health; 2022 Oct; 22(1):1875. PubMed ID: 36207757 [TBL] [Abstract][Full Text] [Related]
9. Can We Predict Incorrect PrEP Use in High HIV Risk Situations Among Men Who Have Sex With Men? An Analysis of Be-PrEP-ared, the Belgian PrEP Demonstration Study. Vuylsteke B; Reyniers T; Nöstlinger C; Smekens T; Kenyon C; Laga M J Acquir Immune Defic Syndr; 2021 Sep; 88(1):36-44. PubMed ID: 34081665 [TBL] [Abstract][Full Text] [Related]
10. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM; Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343 [TBL] [Abstract][Full Text] [Related]
11. Injectable Pre-Exposure Prophylaxis for HIV Prevention: Perspectives on the Benefits and Barriers from Gay, Bisexual, and Queer Men and Health System Stakeholders in Ontario, Canada. Grace D; Gaspar M; Wells A; Sinno J; Daroya E; Montess M; Hull M; Lachowsky NJ; Tan DHS AIDS Patient Care STDS; 2023 Jun; 37(6):306-315. PubMed ID: 37195728 [TBL] [Abstract][Full Text] [Related]
12. Design and Delivery of Real-Time Adherence Data to Men Who Have Sex with Men Using Antiretroviral Pre-exposure Prophylaxis via an Ingestible Electronic Sensor. Chai PR; Goodman G; Bustamante M; Mendez L; Mohamed Y; Mayer KH; Boyer EW; Rosen RK; O'Cleirigh C AIDS Behav; 2021 Jun; 25(6):1661-1674. PubMed ID: 33219877 [TBL] [Abstract][Full Text] [Related]
13. Exploring the Shift From HIV Pre-exposure Prophylaxis Awareness to Uptake Among Young Gay and Bisexual Men. Koester KA; Erguera XA; Udoh I; Kang Dufour MS; Burack JH; Myers JJ Front Public Health; 2021; 9():677716. PubMed ID: 34950622 [No Abstract] [Full Text] [Related]
14. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP). Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439 [TBL] [Abstract][Full Text] [Related]
15. DigiPrEP: A Pilot Trial to Evaluate the Feasibility, Acceptability, and Accuracy of a Digital Pill System to Measure PrEP Adherence in Men Who Have Sex With Men Who Use Substances. Chai PR; Mohamed Y; Bustamante MJ; Goodman GR; Najarro J; Castillo-Mancilla J; Baez A; Bronzi O; Sullivan MC; Pereira LM; Baumgartner SL; Carnes TC; Mayer KH; Rosen RK; Boyer EW; O'Cleirigh C J Acquir Immune Defic Syndr; 2022 Feb; 89(2):e5-e15. PubMed ID: 34753871 [TBL] [Abstract][Full Text] [Related]
16. A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial. Kawichai S; Songtaweesin WN; Wongharn P; Phanuphak N; Cressey TR; Moonwong J; Vasinonta A; Saisaengjan C; Chinbunchorn T; Puthanakit T JMIR Mhealth Uhealth; 2022 Apr; 10(4):e25561. PubMed ID: 35451976 [TBL] [Abstract][Full Text] [Related]
17. Social Support Networks Among Young Men and Transgender Women of Color Receiving HIV Pre-Exposure Prophylaxis. Wood S; Dowshen N; Bauermeister JA; Lalley-Chareczko L; Franklin J; Petsis D; Swyryn M; Barnett K; Weissman GE; Koenig HC; Gross R J Adolesc Health; 2020 Mar; 66(3):268-274. PubMed ID: 31672523 [TBL] [Abstract][Full Text] [Related]
18. Identifying Strategies for Improving Pre-exposure Prophylaxis Adherence: Perspectives from a Sample of Highly Adherent Young Men Who have Sex with Men. Xavier Hall CD; Bundy C; Foran JE; Newcomb ME; Carrillo H; Watkins-Hayes C; Mustanski B AIDS Behav; 2023 Feb; 27(2):506-517. PubMed ID: 35906443 [TBL] [Abstract][Full Text] [Related]
19. Adherence to Daily Oral TDF/FTC for PrEP in Community Health Center Populations: The Sustainable Health Center Implementation PrEP Pilot (SHIPP) Study. Smith DK; Rawlings MK; Glick N; Mena L; Coleman M; Houlberg M; McCallister S; Wiener J AIDS Behav; 2022 Feb; 26(2):350-360. PubMed ID: 34347198 [TBL] [Abstract][Full Text] [Related]
20. PrEP risk perception and adherence among men who have sex with men: a prospective cohort study based on growth mixture model. Lin B; Liu J; Zhong X BMC Infect Dis; 2022 Dec; 22(1):969. PubMed ID: 36585642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]